Published in J Am Soc Nephrol on August 01, 2003
Transcriptome analysis of human diabetic kidney disease. Diabetes (2011) 2.32
New pharmacological treatments for improving renal outcomes in diabetes. Nat Rev Nephrol (2010) 1.29
Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Hum Genet (2007) 1.25
The pathogenic role of Notch activation in podocytes. Nephron Exp Nephrol (2009) 1.17
Advances in murine models of diabetic nephropathy. J Diabetes Res (2013) 0.88
Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus. BMC Med Genomics (2009) 0.83
Glomerular Endothelial Mitochondrial Dysfunction is Essential and Characteristic of Diabetic Kidney Disease Susceptibility. Diabetes (2016) 0.75
The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy. Endocrine (2017) 0.75
TGF-beta and epithelial-to-mesenchymal transitions. Oncogene (2005) 10.02
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab (2008) 6.22
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes (2006) 5.29
Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J (2004) 4.77
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2004) 3.95
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2009) 3.74
Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Kidney Int (2009) 3.19
Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest (2008) 3.11
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol (2008) 3.02
Pathogenesis and management of hypertension after kidney transplantation. J Hypertens (2011) 2.66
Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol (2003) 2.44
Hierarchical model of gene regulation by transforming growth factor beta. Proc Natl Acad Sci U S A (2003) 2.37
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
A simplified method for HPLC determination of creatinine in mouse serum. Am J Physiol Renal Physiol (2004) 2.17
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int (2005) 2.02
Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int (2004) 2.00
TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int (2004) 1.95
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun (2012) 1.88
Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol (2009) 1.86
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest (2013) 1.84
Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol (2006) 1.82
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol (2008) 1.79
Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol (2007) 1.75
A1C and survival in maintenance hemodialysis patients. Diabetes Care (2007) 1.75
Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol (2010) 1.75
Selective role for superoxide in InsP3 receptor-mediated mitochondrial dysfunction and endothelial apoptosis. J Cell Biol (2005) 1.73
Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med (2005) 1.71
A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J Biol Chem (2004) 1.70
Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol (2011) 1.64
Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol (2007) 1.63
Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease. Am J Physiol Renal Physiol (2013) 1.63
Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov (2012) 1.63
TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol (2005) 1.61
Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes (2004) 1.58
The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res (2009) 1.58
Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. Am J Physiol Renal Physiol (2005) 1.58
Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes. Metabolism (2012) 1.55
Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol (2012) 1.51
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest (2011) 1.49
The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer (2004) 1.49
AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol (2011) 1.48
Deficits in sialylation impair podocyte maturation. J Am Soc Nephrol (2012) 1.47
ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosis. Nephrol Dial Transplant (2010) 1.44
A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation. Transpl Int (2015) 1.39
Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. Nephrol Dial Transplant (2011) 1.36
Novel regulators of kidney development from the tips of the ureteric bud. J Am Soc Nephrol (2005) 1.33
Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clin Cancer Res (2005) 1.32
Pirfenidone is renoprotective in diabetic kidney disease. J Am Soc Nephrol (2009) 1.29
New pharmacological treatments for improving renal outcomes in diabetes. Nat Rev Nephrol (2010) 1.29
Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes (2005) 1.25
Role of Nox2 in diabetic kidney disease. Am J Physiol Renal Physiol (2013) 1.24
Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells. Kidney Int (2003) 1.24
Overview: combating diabetic nephropathy. J Am Soc Nephrol (2003) 1.22
Decorin deficiency enhances progressive nephropathy in diabetic mice. Am J Pathol (2007) 1.22
Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med (2009) 1.21
Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics (2005) 1.21
Role of upstream stimulatory factors in regulation of renal transforming growth factor-beta1. Diabetes (2005) 1.21
Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. Semin Nephrol (2007) 1.20
Cofilin-1 inactivation leads to proteinuria--studies in zebrafish, mice and humans. PLoS One (2010) 1.20
Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol Dial Transplant (2008) 1.19
Independent predictors of acute appendicitis on CT with pathologic correlation. Acad Radiol (2008) 1.18
Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Renal Physiol (2008) 1.18
Diabetic nephropathy: a frontier for personalized medicine. J Am Soc Nephrol (2006) 1.18
PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia. J Biol Chem (2011) 1.17
TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. J Am Soc Nephrol (2009) 1.16
The endoplasmic reticulum stress response and diabetic kidney disease. Am J Physiol Renal Physiol (2011) 1.16
Inhibitory smads and tgf-Beta signaling in glomerular cells. J Am Soc Nephrol (2002) 1.15
Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol (2009) 1.15
Concordant loss of fragile gene expression early in breast cancer development. Pathol Int (2005) 1.15
Obesity related kidney disease. Curr Diabetes Rev (2011) 1.14
CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes. J Biol Chem (2010) 1.13
Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract (2010) 1.13
Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease. Proc Natl Acad Sci U S A (2008) 1.13
Sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Curr Opin Nephrol Hypertens (2010) 1.12
The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol (2009) 1.12
Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer (2005) 1.11
Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens (2009) 1.09
TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. Am J Physiol Renal Physiol (2010) 1.08
Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts. J Am Soc Nephrol (2005) 1.07
Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation (2006) 1.07
Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol (2007) 1.07
Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol (2004) 1.06
B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant (2009) 1.06
Glycemic control in diabetic CKD patients: where do we stand? Am J Kidney Dis (2008) 1.05
The role of aldosteronism in causing obesity-related cardiovascular risk. Cardiol Clin (2010) 1.04
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. Mod Pathol (2009) 1.03
Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain. Diabetes (2007) 1.02